Tool Developed To Help Study Prostate Cancer RedOrbit Prostate cancer is the most common form of cancer in men, with more than 192000 new cases and more than 27000 deaths reported in the United States in 2009 ...
Kidney Transplant Patient Lives 40 Years WPXI Pittsburgh And just two years ago they discovered I had prostate cancer also, so I've gone through radiation and chemo and you just can't keep a good man down, ...
How New Jersey's Top Hospitals were selected The Star-Ledger - NJ.com Doctors were asked to vote for the five leading hospitals for treatment of the following medical conditions: breast cancer; prostate cancer; ...
VAI Researchers Develop Tool to Help Study Prostate Cancer PharmaLive (press release) (subscription) Prostate cancer is the most common form of cancer in men, with more than 192000 new cases and more than 27000 deaths reported in the United States in 2009 ...
Kidney Transplant Patient Lives 40 Years KFOX El Paso And just two years ago they discovered I had prostate cancer also, so I've gone through radiation and chemo and you just can't keep a good man down, ...
Ride for Dad marks ten years with cross-country tour Ottawa Citizen Since then the event has spread to more than two dozen cities and raised more than $5 million for prostate cancer awareness. The local rides will again take ...
PSA Test Reduces Prostate Cancer Deaths by 40% Your-Story.org (press release) "The long-term solution is to discover a new biomarker for prostate cancer without false positives or negatives and one that determines who has a ...
PSA Test Reduces Prostate Cancer Deaths by 40% SunHerald.com (press release) "The long-term solution is to discover a new biomarker for prostate cancer without false positives or negatives and one that determines who has a ...
Finding And Curing Prostate Cancer Forbes As a primary care doctor who screens for prostate cancer every day, I can tell you that this disease is both common and potentially deadly. ...
PSA Test Reduces Prostate Cancer Deaths by 40% Article Ant (press release) "The long-term solution is to discover a new biomarker for prostate cancer without false positives or negatives and one that determines who has a ...
